This volume covers drugs available for disorders of the central nervous system. This book examines options on the design of clinical trials and questions the need for prolonged testing in some areas, based on evidence from real examples. It includes examples for the pharmaceutical industry.
Read More
This volume covers drugs available for disorders of the central nervous system. This book examines options on the design of clinical trials and questions the need for prolonged testing in some areas, based on evidence from real examples. It includes examples for the pharmaceutical industry.
Read Less
